Biomarkers point to which lymphoma patients respond to dasatinib
A Phase II trial in Japan identified TCR signaling mutations and clonal hematopoiesis burden as biomarkers predicting dasatinib response in ...
A Phase II trial in Japan identified TCR signaling mutations and clonal hematopoiesis burden as biomarkers predicting dasatinib response in ...
A new perspective examines a recent study reporting that telomeres in mouse tails and leukocytes do not shorten with age, ...
A retrospective Korean study found that combining sequencing-based residual disease testing with donor chimerism assessment three months after transplant stratified ...
A peer-reviewed review proposes that chronic DNA damage response signaling may connect senescence, inflammation and other aging processes, while emphasizing ...
A new review argues that inherited HLA, MICA/MICB and KIR variation may influence whether CALR-mutant clones in myeloproliferative neoplasms are ...
A case report and literature review describe acute myeloid leukemia developing 32 months into icotinib therapy for EGFR-mutated lung cancer, ...
A sweeping review of population-scale genomic data reveals that loss of the X chromosome is the most common mosaic chromosomal ...
The practical framework outlined by Zhang and Madlensky arrives at a moment when the infrastructure of precision oncology is being ...
A large Mendelian randomization study links genetically predicted clonal hematopoiesis of indeterminate potential to increased risks of six cancer types, ...
An autopsy-confirmed case reveals shared STAT3 and TET2 mutations linking Felty syndrome to terminal aggressive clonal T-cell disease.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine